[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335002-105":59,"doc-detail-335002-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","dr-70-fibrinogen-fibrin-degradation-products-as-a-prognostic-biomarker-in-dogs-with-neoplasms","DR-70 (Fibrinogen-Fibrin Degradation Products) as a Prognostic Biomarker in Dogs with Neoplasms","","Fibrinogen–fibrin degradation products (DR-70) originate from tumor cells or metastases, and prior diagnostic work in dogs with tumors lacked prognostic validation. This study assessed DR-70 concentration changes and clinical disease courses in tumor-bearing dogs using overall survival time analysis in 195 dogs with tumors and continual DR-70 monitoring during intervention in 27 dogs. A cut-off of 1.514 µg/mL distinguished shorter survival, with decreases during complete/partial remission and increases during progression, supporting DR-70 for prognosis and treatment response monitoring.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/dr-70-fibrinogen-fibrin-degradation-products-as-a-prognostic-biomarker-in-dogs-with-neoplasms/335002/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/dr-70-fibrinogen-fibrin-degradation-products-as-a-prognostic-biomarker-in-dogs-with-neoplasms/335002.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-12","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is DR-70, and why is it relevant to prognosis in dogs with tumors?","Question",{"text":112,"@type":113},"DR-70 (fibrinogen–fibrin degradation products) is generated through coagulation and fibrinolysis associated with tumor formation and metastasis. Its concentration is evaluated here to determine prognostic usefulness beyond diagnostic differentiation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was overall survival assessed in the study?",{"text":117,"@type":113},"Overall survival time (OST) analysis was performed in 195 tumor-bearing dogs. Dogs were stratified using a recommended DR-70 cut-off value of 1.514 µg/mL.",{"name":119,"@type":110,"acceptedAnswer":120},"How do DR-70 levels change with treatment response and disease progression?",{"text":121,"@type":113},"In cases with complete or partial remission, DR-70 concentration decreased compared with the first visit, while it increased in patients showing disease progression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335002,1790738881,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Veterinary Quarterly 2024, VOl. 44, nO. 1, 1–10  \n[https://doi.org/10.1080/01652176.2024.2380049](https://doi.org/10.1080/01652176.2024.2380049)  \nDR-70 (fibrinogen-fibrin degradation products) as a prognostic biomarker in dogs with neoplasms  \nChiao-Hsu Kea, Chen-Si Lina, Ka-Mei Sioa,b, Chun-Hung Wuc, Yuan-Yuan Xiad,e,f, Jih-Jong Leed,e,f, Chin-Hao Hug, Cheng-Chi Liua, Bor-Song Liawg, Chiao-Lei Chengb, Keng-Hsuan Linh and  \nYu-Shan Wanga,b  \naDepartment of Veterinary Medicine, School of Veterinary Medicine, national taiwan university, taipei, taiwan; buni-Pharma Co-ltd, taipei, taiwan; cWellcarevet animal Hospital, taipei, taiwan; dGraduate institute of Veterinary Clinical Science, School of Veterinary Medicine, national taiwan university, taipei, taiwan; eanimal Cancer Center, College of Bioresources and agriculture, national taiwan university, taipei, taiwan; fnational taiwan university Veterinary Hospital, College of Bioresources and agriculture, national taiwan university, taipei, taiwan; glifecare animal Hospital, taipei, taiwan; hthoughtful animal Hospital, taoyuan, taiwan  \nABSTRACT  \nFibrinogen–fibrin degradation products (DR-70) are derived from tumor cells or metastases. Our previous study reported the diagnostic values in dogs with tumors, but no research has yet to be conducted to establish DR-70 as a prognostic marker. Herein, we investigated changes in DR-70 concentrations and disease courses in dogs with tumors. Overall survival time (OST) analysis was performed in 195 dogs with tumors, stratified with a recommended cut-off (1.514 µg/mL). Continual DR-70 measurements were performed during the medical interventions of 27 dogs with neoplasms. Clinical conditions and medical records were retrospectively reviewed. According to a cut-off value, dogs with plasma DR-70 concentrations above 1.514 µg/mL had shorter survival rates than those with concentrations below this threshold. In cases with complete or partial remission in response to treatment, the DR-70 concentration was decreased compared with that at the first visit, whereas it was increased inpatients with disease progression. Our study suggested that changes in DR-70 concentration can be used as a prognostic biomarker for canine neoplasms. Furthermore, increased plasma DR-70 levels might be associated with shorter survival, and DR-70 concentrations may reflect responses to medical intervention.  \nARTICLE HISTORY  \nReceived 20 November 2023  \nAccepted 10 July 2024  \nKEYWORDS  \nDR-70; fibrinogen-fibrin degradation products; prognostic biomarker; tumor monitoring  \n1. Introduction  \nTumors usually produce tumor biomarkers, which can often reflect disease progression (Duffy 2013; Faria et al. 2019). The ideal tumor biomarker would be easy to measure with high sensitivity and specificity, facilitating effective identification of dogs with neoplasms at the earliest stage (Colombe et al. 2022). In veterinary medicine, owing to convenience, most biomarkers are protein-based, including carcinomaembryogenic antigen (CEA) (Campos et al. 2012; Valencakova-Agyagosova et al. 2014; Senhorello et al. 2020; Fan et al. 2021), carbohydrate antigen 15-3 (CA15-3) (Campos et al. 2012; Manuali et al. 2012; Valencakova-Agyagosova et al. 2014; Fan et al. 2021), alpha-fetoprotein (AFP) (Kitao et al. 2006), and lactate dehydrogenase (LDH) (Campos et al. 2012). The next generation of biomarkers focused on discovering micro RNAs (Heishima et al. 2015; 2017), circulating-tumor DNA (Prouteau et al. 2021; Favaro et al. 2022),  \ncell-free DNA (Beck et al. 2013; Beffagna et al. 2017), and circulating tumor cells (CTCs) (Marconato et al. 2019; Wright et al. 2019), has gradually been developed. Nevertheless, these scientific studies have only reported tumor biomarkers that can differentiate dogs with tumors from healthy individuals. They offer limited predictive evidence on responses to medical intervention. Furthermore, increasing attention has been paid to the clinical application of prognost","cbCaid14iNNo0Csr","https://ap.wps.com/l/cbCaid14iNNo0Csr","pdf",1093285,"English","# Abstract\n# Introduction\n## Tumor biomarkers and prognostic value\n## Hemostatic biomarkers and DR-70 rationale","[{\"question\":\"What is DR-70, and why is it relevant to prognosis in dogs with tumors?\",\"answer\":\"DR-70 (fibrinogen–fibrin degradation products) is generated through coagulation and fibrinolysis associated with tumor formation and metastasis. Its concentration is evaluated here to determine prognostic usefulness beyond diagnostic differentiation.\"},{\"question\":\"How was overall survival assessed in the study?\",\"answer\":\"Overall survival time (OST) analysis was performed in 195 tumor-bearing dogs. Dogs were stratified using a recommended DR-70 cut-off value of 1.514 µg/mL.\"},{\"question\":\"How do DR-70 levels change with treatment response and disease progression?\",\"answer\":\"In cases with complete or partial remission, DR-70 concentration decreased compared with the first visit, while it increased in patients showing disease progression.\"}]","DR-70 (Fibrinogen-Fibrin Degradation Products) as a Prognostic Biomarker in Dogs with Neoplasms | PDF",1790009181,25]